High-dose chemotherapy with hematopoietic stem cell support as consolidation therapy for patients with platinum-sensitive advanced epithelial ovarian cancer

Bone Marrow Transplantation

Volumn 22, Issue SUPPL. 3, 1998, Pages

  Cure, H ^a   Extra, J M ^b   Viens, P ^c   Lotz, J P ^d   Guastalla, J P ^e   Dieras, V ^f   Legros, M ^a   Maraninchi, D ^c   Izrael, V ^d   Pouillart, P ^f   Marty, M ^b   Plagne, R ^a  

^a CENTRE JEAN PERRIN   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c INSTITUT PAOLI CALMETTES   (France)

^d HÔPITAL TENON   (France)

^e CENTRE LÉON BÉRARD   (France)

^f INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0013665401     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Curé H, Legros M, Fleury J et al. High-dose chemotherapy and autologous stem cell transplantation in advanced epithelial ovarian cancer. Bone Marrow Transplantation 1996, 18 (suppl 1), abstract p. S34.
2. Legros M, Dauplat J, Fleury J et al. High dose chemotherapy with hematopoietic rescues in patients with stage III to IV ovarian cancer : long-term results Journal of Clinical Oncology 1997, 15, 1302-1308
3. Viens P, Maraninchi D, Legros M et al. High-dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas. Bone Marrow Transplant 1990, 5, 227-233.
4. Extra J.M, Curé H, Viens P et al. High-dose chemotherapy with autologous bone marrow transplantation in ovarian adeno-carcinoma. Bull Cancer 1993; 80: 156-162.